<table class="dataGrid" cellspacing="0" cellpadding="1" border="0"><colgroup span="2"></colgroup><colgroup span="5"></colgroup><thead><tr><td>&nbsp;</td><td width="2%" class="noprint" style="background-color: #f2f3ee;">&nbsp;</td><th id="AllABO">All ABO</th><th id="O">O</th><th id="A">A</th><th id="B">B</th><th id="AB">AB</th></tr></thead><tbody><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;All Diagnoses</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AllABO">125,743</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="O">66,117</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="A">36,494</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="B">19,902</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AB">3,230</td></tr><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;Acute Hepatic Necrosis</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #ffffff;" headers="AllABO">239</td><td align="right" width="14%" style="background-color: #ffffff;" headers="O">122</td><td align="right" width="14%" style="background-color: #ffffff;" headers="A">83</td><td align="right" width="14%" style="background-color: #ffffff;" headers="B">25</td><td align="right" width="14%" style="background-color: #ffffff;" headers="AB">9</td></tr><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;Alpha-1 - Antitrypsin Deficiency</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AllABO">53</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="O">31</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="A">19</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="B">1</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AB">2</td></tr><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;Benign Neoplasms</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #ffffff;" headers="AllABO">109</td><td align="right" width="14%" style="background-color: #ffffff;" headers="O">62</td><td align="right" width="14%" style="background-color: #ffffff;" headers="A">33</td><td align="right" width="14%" style="background-color: #ffffff;" headers="B">12</td><td align="right" width="14%" style="background-color: #ffffff;" headers="AB">2</td></tr><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;Biliary Atresia</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AllABO">226</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="O">119</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="A">63</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="B">39</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AB">5</td></tr><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;Cardiomyopathy</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #ffffff;" headers="AllABO">2,077</td><td align="right" width="14%" style="background-color: #ffffff;" headers="O">1,233</td><td align="right" width="14%" style="background-color: #ffffff;" headers="A">578</td><td align="right" width="14%" style="background-color: #ffffff;" headers="B">232</td><td align="right" width="14%" style="background-color: #ffffff;" headers="AB">34</td></tr><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;Cholestatic Liver Disease/Cirrhosis</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AllABO">1,030</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="O">474</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="A">405</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="B">126</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AB">25</td></tr><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;Congenital Heart Disease</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #ffffff;" headers="AllABO">403</td><td align="right" width="14%" style="background-color: #ffffff;" headers="O">234</td><td align="right" width="14%" style="background-color: #ffffff;" headers="A">109</td><td align="right" width="14%" style="background-color: #ffffff;" headers="B">49</td><td align="right" width="14%" style="background-color: #ffffff;" headers="AB">11</td></tr><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;Congenital, Rare, Familial, and Metaboli</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AllABO">1,367</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="O">711</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="A">418</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="B">207</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AB">31</td></tr><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;Coronary Artery Disease</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #ffffff;" headers="AllABO">1,081</td><td align="right" width="14%" style="background-color: #ffffff;" headers="O">584</td><td align="right" width="14%" style="background-color: #ffffff;" headers="A">348</td><td align="right" width="14%" style="background-color: #ffffff;" headers="B">132</td><td align="right" width="14%" style="background-color: #ffffff;" headers="AB">17</td></tr><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;Cystic Fibrosis</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AllABO">119</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="O">65</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="A">36</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="B">10</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AB">8</td></tr><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;Diabetes</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #ffffff;" headers="AllABO">37,691</td><td align="right" width="14%" style="background-color: #ffffff;" headers="O">19,841</td><td align="right" width="14%" style="background-color: #ffffff;" headers="A">10,605</td><td align="right" width="14%" style="background-color: #ffffff;" headers="B">6,319</td><td align="right" width="14%" style="background-color: #ffffff;" headers="AB">926</td></tr><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;Emphysema/COPD</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AllABO">379</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="O">202</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="A">126</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="B">43</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AB">8</td></tr><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;Functional Bowel Problems</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #ffffff;" headers="AllABO">50</td><td align="right" width="14%" style="background-color: #ffffff;" headers="O">26</td><td align="right" width="14%" style="background-color: #ffffff;" headers="A">15</td><td align="right" width="14%" style="background-color: #ffffff;" headers="B">6</td><td align="right" width="14%" style="background-color: #ffffff;" headers="AB">3</td></tr><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;Glomerular Disease</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AllABO">16,861</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="O">9,073</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="A">4,555</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="B">2,798</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AB">435</td></tr><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;Hypertensive Nephrosclerosis</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #ffffff;" headers="AllABO">20,635</td><td align="right" width="14%" style="background-color: #ffffff;" headers="O">11,352</td><td align="right" width="14%" style="background-color: #ffffff;" headers="A">5,023</td><td align="right" width="14%" style="background-color: #ffffff;" headers="B">3,771</td><td align="right" width="14%" style="background-color: #ffffff;" headers="AB">489</td></tr><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;Idiopathic Pulmonary Fibrosis</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AllABO">260</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="O">141</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="A">75</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="B">36</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AB">8</td></tr><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;Malignant Neoplasms</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #ffffff;" headers="AllABO">1,142</td><td align="right" width="14%" style="background-color: #ffffff;" headers="O">560</td><td align="right" width="14%" style="background-color: #ffffff;" headers="A">404</td><td align="right" width="14%" style="background-color: #ffffff;" headers="B">143</td><td align="right" width="14%" style="background-color: #ffffff;" headers="AB">35</td></tr><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;Metabolic Disease</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AllABO">239</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="O">111</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="A">96</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="B">29</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AB">3</td></tr><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;Neoplasms</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #ffffff;" headers="AllABO">264</td><td align="right" width="14%" style="background-color: #ffffff;" headers="O">134</td><td align="right" width="14%" style="background-color: #ffffff;" headers="A">78</td><td align="right" width="14%" style="background-color: #ffffff;" headers="B">43</td><td align="right" width="14%" style="background-color: #ffffff;" headers="AB">9</td></tr><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;Non-Cholestatic Cirrhosis</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AllABO">9,912</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="O">4,717</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="A">3,889</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="B">1,068</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AB">238</td></tr><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;Not Reported</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #ffffff;" headers="AllABO">2,304</td><td align="right" width="14%" style="background-color: #ffffff;" headers="O">1,139</td><td align="right" width="14%" style="background-color: #ffffff;" headers="A">768</td><td align="right" width="14%" style="background-color: #ffffff;" headers="B">316</td><td align="right" width="14%" style="background-color: #ffffff;" headers="AB">81</td></tr><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;Other</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AllABO">10,657</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="O">5,703</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="A">3,100</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="B">1,580</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AB">274</td></tr><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;Other Lung Disease</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #ffffff;" headers="AllABO">352</td><td align="right" width="14%" style="background-color: #ffffff;" headers="O">183</td><td align="right" width="14%" style="background-color: #ffffff;" headers="A">110</td><td align="right" width="14%" style="background-color: #ffffff;" headers="B">44</td><td align="right" width="14%" style="background-color: #ffffff;" headers="AB">15</td></tr><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;Polycystic Kidneys</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AllABO">6,698</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="O">3,535</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="A">2,015</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="B">985</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AB">163</td></tr><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;Primary Pulmonary Hypertension</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #ffffff;" headers="AllABO">98</td><td align="right" width="14%" style="background-color: #ffffff;" headers="O">53</td><td align="right" width="14%" style="background-color: #ffffff;" headers="A">23</td><td align="right" width="14%" style="background-color: #ffffff;" headers="B">20</td><td align="right" width="14%" style="background-color: #ffffff;" headers="AB">2</td></tr><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;Renovascular and Other Vascular Disease</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AllABO">1,037</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="O">594</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="A">243</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="B">175</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AB">25</td></tr><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;Retransplant/Graft Failure</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #ffffff;" headers="AllABO">7,114</td><td align="right" width="14%" style="background-color: #ffffff;" headers="O">3,422</td><td align="right" width="14%" style="background-color: #ffffff;" headers="A">2,196</td><td align="right" width="14%" style="background-color: #ffffff;" headers="B">1,224</td><td align="right" width="14%" style="background-color: #ffffff;" headers="AB">272</td></tr><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;Short Gut Syndrome</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AllABO">131</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="O">67</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="A">41</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="B">17</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AB">6</td></tr><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;Tubular and Interstitial Diseases</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #ffffff;" headers="AllABO">3,178</td><td align="right" width="14%" style="background-color: #ffffff;" headers="O">1,614</td><td align="right" width="14%" style="background-color: #ffffff;" headers="A">1,027</td><td align="right" width="14%" style="background-color: #ffffff;" headers="B">445</td><td align="right" width="14%" style="background-color: #ffffff;" headers="AB">92</td></tr><tr><th style="text-align: left; background-color: #ffffff; font-weight: normal; font-size: 11px; color: #000000; " width="25%" nowrap="nowrap">&nbsp;Valvular Heart Disease</th><td width="2%" class="noprint" style="background-color: #f2f3ee; min-width: 22px;">&nbsp;</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AllABO">37</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="O">15</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="A">13</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="B">7</td><td align="right" width="14%" style="background-color: #e1edf3;" headers="AB">2</td></tr></tbody></table>